615
Views
38
CrossRef citations to date
0
Altmetric
LABORATORY STUDY

Beneficial Effect of Pentoxifylline on Cisplatin-Induced Acute Renal Failure in Rabbits

, Ph.D., , , , &
Pages 909-922 | Published online: 07 Jul 2009

References

  • Inselmann G., Blomer A., Kottny W., Nellessen U., Hanel H., Heidemann H.T. Modification of cisplatin-induced renal p-aminohippurate uptake alteration and lipid peroxidation by thiols, Ginkgo biloba extract, deferoxamine and torbafylline. Nephron 1995; 70: 425–429
  • Garnick M.B., Mayer R.J., Abelson H.T. Acute renal failure associated with cancer treatment. Acute Renal Failure, B.M. Brenner, J.M. Lazarus. Churchill Livingtone, New York 1988; 621–657
  • Madias N.E., Harrington J.T. Platinum nephrotoxicity. Am. J. Med. 1978; 65: 307–314
  • Diamond J.R., Pesek I. Glomerular tumor necrosis factor and interleukin 1 during acute aminonucleoside nephrosis. An immunohistochemical study. Lab. Invest. 1991; 64: 21–28
  • Egido J., Gomez C.M., Ortiz A., Bustos C., Alonso J., Gomez G.C., Gomez G.D., Lopez A.M., Plaza J., Gonzalez E. Role of tumor necrosis factor-alpha in the pathogenesis of glomerular diseases. Kidney Int. 1993; 39: S59–S64
  • Tipping P.G., Leong T.W., Holdsworth S.R. Tumor necrosis factor production by glomerular macrophages in anti-glomerular basement membrane glomerulonephritis in rabbits. Lab. Invest. 1991; 65: 272–279
  • Mulligan M.S., Johnson K.J., Todd R.F., Issekutz T.B., Miyasaka M., Tamatani T., Smith C.W., Anderson D.C., Ward P.A. Requirements for leukocyte adhesion molecules in nephrotoxic nephritis. J. Clin. Invest. 1993; 91: 577–587
  • Navarro J.F., Mora C., Rivero A., Gallego E., Chahin J., Macia M., Mendez M.L., Garcia J. Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration. Am. J. Kidney Dis. 1999; 33: 458–463
  • Baud L., Ardaillou R. Tumor necrosis factor alpha in glomerular injury. Kidney Int. Suppl. 1994; 45: S32–S36
  • Meldrum K.K., Meldrum D.R., Hile K.L., Yerkes E.B., Ayala A., Cain M.P., Rink R.C., Casale A.J., Kaefer M.A. p38 MAPK mediates renal tubular cell TNF-alpha production and TNF-alpha-dependent apoptosis during simulated ischemia. Am. J. Physiol. Cell Physiol. 2001; 281: C563–C570
  • Gillings D.B. Pentoxifylline and intermittent claudication: review of clinical trials and cost-effectiveness analyses. J. Cardiovasc. Pharmacol. 1995; 25(suppl. 2)544–550
  • Staudinger T., Presterl E., Graninger W., Locker G.J., Knapp S., Laczika K., Klappacher G., Stoiser B., Wagner A., Tesinsky P., Kordova H., Frass M. Influence of pentoxifylline on cytokine levels and inflammatory parameters in septic shock. Intensive Care Med. 1996; 22: 888–893
  • Strieter R.M., Remick D.G., Ward P.A., Spengler R.N., Lynch J.P., Larrick J., Kunkel S.L. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem. Biophys. Res. Commun. 1998; 155: 1230–1236
  • Brunner L.J., Vadiei K., Iyer L.V., Luke D.R. Prevention of cyclosporine-induced nephrotoxicity with pentoxifylline. Ren. Fail. 1989; 11: 97–104
  • Vadiei K., Brunner L.J., Luke D.R. Effects of pentoxifylline in experimental acute renal failure. Kidney Int. 1989; 36: 466–470
  • Uchiyama M., Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 1978; 86: 271–278
  • Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248–254
  • Ciuffetti G., Mercuri M., Ott C., Lombardini R., Paltriccia R., Lupattelli G., Santambrogio L., Mannarino E. Use of pentoxifylline as an inhibitor of free radical generation in peripheral vascular disease. Results of a double-blind placebo-controlled study. Eur. J. Clin. Pharmacol. 1991; 41: 511–515
  • Franzini E., Sellak H., Hakim J., Pasquier C. Oxidative damage to lysozyme by the hydroxyl radical: comparative effects of scavengers. Biochim. Biophys. Acta. 1993; 1203: 11–17
  • Sinzinger H. Pentoxifylline enhances formation of prostacyclin from rat vascular and renal tissue. Prostaglandins Leukot. Med. 1983; 12: 217–226
  • Ward A., Clissold S.P. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 1987; 34: 50–97
  • Luke D.R., Vadiei K., Lopez-Berestein G. Role of vascular congestion in cisplatin-induced acute renal failure in the rat. Nephrol. Dial. Transplant. 1992; 7: 1–7
  • Lieberthal W., Triaca V., Levine J. Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am. J. Physiol. 1996; 270: F700–F708
  • Goldstein R.S., Noordewier B., Bond J.T., Hook J.B., Mayor G.H. cis-Dichlorodiammineplatinum nephrotoxicity: time course and dose response of renal functional impairment. Toxicol. Appl. Pharmacol. 1981; 60: 163–175
  • Kim Y.K., Byun H.S., Kim Y.H., Woo J.S., Lee S.H. Effect of cisplatin on renal function in rabbits: mechanism of reduced glucose reabsorption. Toxicol. Appl. Pharmacol. 1995; 130: 19–26
  • Lee R.H., Song J.M., Park M.Y., Kang S.K., Kim Y.K., Jung J.S. Cisplatin-induced apoptosis by translocation of endogenous Bax in mouse collecting duct cells. Biochem. Pharmacol. 2001; 62: 1013–1023
  • Zhou H., Miyaji T., Kato A., Fujigaki Y., Sano K., Hishida A. Attenuation of cisplatin-induced acute renal failure is associated with less apoptotic cell death. J. Lab. Clin. Med. 1999; 134: 649–658
  • Hannemann J., Baumann K. Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: different effects of antioxidants and radical scavengers. Toxicology 1988; 51: 119–132
  • Balde G.S., van den Hamer C.J., Los G., Vermeulen N.P., de Goeij J.J., McVie J.G. Selenium-induced protection against cis-diaminedichloroplatinum (II) nephrotoxicity in mice and rats. Cancer Res. 1989; 49: 3020–3023
  • Basinger M.A., Jones M.M., Holscher M.A. l-Methionine antagonism of cis-platinum nephrotoxicity. Toxicol. Appl. Pharmacol. 1990; 103: 1–15
  • Vadiei K., Brunner L.J., Luke D.R. Effects of pentoxifylline in experimental acute renal failure. Kidney Int. 1989; 36: 466–470
  • Jackson E.K. Renal actions of purines. Purinergic Approaches in Experimental Therapeutics, K.A. Jackson, M.F. Jarvis. John Wiley & Sons, Inc., New York 1997; 217–250
  • Agarwal A., Balla J., Alam J., Croatt A.J., Nath K.A. Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat. Kidney Int. 1995; 48: 1298–1307
  • Jeong J.C., Hwang W.M., Yoon C.H., Kim Y.K. Salviae radix extract prevents cisplatin-induced acute renal failure in rabbits. Nephron 2001; 88: 241–246
  • Vilcek J., Lee T.H. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J. Biol. Chem. 1991; 266: 7313–7316
  • Peralta Soler A., Mullin J.M., Knudsen K.A., Marano C.W. Tissue remodeling during tumor necrosis factor-induced apoptosis in LLC-PK1 renal epithelial cells. Am. J. Physiol. 1996; 270: F869–F879
  • Palma J.P., Aggarwal S.K. Cisplatin and carboplatin-mediated activation of murine peritoneal macrophages in vitro: production of interleukin-1 alpha and tumor necrosis factor-alpha. Anticancer Drugs 1995; 6: 311–316
  • Okamoto M., Kasetani H., Kaji R., Goda H., Ohe G., Yoshida H., Sato M. cis-Diaminedichloroplatinum and 5-fluorouracil are potent inducers of the cytokines and natural killer cell activity in vivo and in vitro. Cancer Immunol. Immunother. 1998; 47: 233–241
  • Riesbeck K. Cisplatin at clinically relevant concentrations enhances interleukin-2 synthesis by human primary blood lymphocytes. Anticancer Drugs 1999; 10: 219–227
  • Loftis L.L., Meals E.A., English B.K. Differential effects of pentoxifylline and interleukin-10 on production of tumor necrosis factor and inducible nitric oxide synthase by murine macrophages. J. Infect. Dis. 1997; 175: 1008–1011

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.